USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke REQUINATE wurde als Wortmarke am 13.06.2003 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 06.03.2007 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".
| Markenform | Wortmarke |
| Aktenzeichen | 78262195 |
| Registernummer | 3214652 |
| Anmeldedatum | 13. Juni 2003 |
| Veröffentlichungsdatum | 05. September 2006 |
| Eintragungsdatum | 06. März 2007 |
Markeninhaber
The Oxford Science Park
OX4 4GA Oxford
GB
OX4 4GA Oxford
GB
Markenvertreter
Waren und Dienstleistungen
1
Chemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology
5
Gene therapy and prophylaxis products, namely, gene delivery, gene transfer, gene regulation and gene modulation for the treatment of hemophilia, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders
42
Scientific and medical research and development; engineering services; biotechnology services, namely, research for others in the field of biotechnology, biotechnology research in the development of therapeutic and prophylactic products and vaccines; licensing of intellectual property; advisory services relating to the research and development of gene therapy and prophylaxis products; consultation services in the field of medical and scientific research in the field of professional gene therapy; medical research and development in the field of vector production technologies
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1378262195